Evidence-informed management of chronic low back pain with prolotherapy

被引:8
作者
Dagenais, Simon [1 ,2 ,3 ]
Mayer, John [3 ,4 ,5 ]
Haldeman, Scott [6 ,7 ]
Borg-Stein, Joanne [8 ,9 ,10 ]
机构
[1] Univ Ottawa, Fac Med, Dept Orthopaed Surg, Ottawa, ON, Canada
[2] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada
[3] CAM Res Inst, Irvine, CA USA
[4] US Spine & Sport Fdn, San Diego, CA USA
[5] Univ S Florida, Coll Med, Sch Phys Therapy & Rehabil Sci, Tampa, FL USA
[6] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[7] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90024 USA
[8] Spaulding Rehabil Hosp, Boston, MA USA
[9] Newton Wellesley Hosp, Spine Ctr, Newton, MA USA
[10] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA
关键词
chronic low back pain; prolotherapy; intraligamentous injection;
D O I
10.1016/j.spinee.2007.10.021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EDITORS' PREFACE: The management of chronic low back pain (CLBP) has proven to be very challenging in North America, as evidenced by its mounting socioeconomic burden. Choosing among available nonsurgical therapies can be overwhelming for many stakeholders, including patients, health providers, policy makers, and third-party payers. Although all parties share a common goal and wish to use limited health-care resources to support interventions most likely to result in clinically meaningful improvements, there is often uncertainty about the most appropriate intervention for a particular patient. To help understand and evaluate the various commonly used nonsurgical approaches to CLBP, the North American Spine Society has sponsored this special focus issue of The Spine Journal, titled Evidence-Informed Management of Chronic Low Back Pain Without Surgery. Articles in this special focus issue were contributed by leading spine practitioners and researchers, who were invited to summarize the best available evidence for a particular intervention and encouraged to make this information accessible to nonexperts. Each of the articles contains five sections (description, theory, evidence of efficacy, harms, and summary) with common subheadings to facilitate comparison across the 24 different interventions profiled in this special focus issue, blending narrative and systematic review methodology as deemed appropriate by the authors. It is hoped that articles in this special focus issue will be informative and aid in decision making for the many stakeholders evaluating nonsurgical interventions for CLBP. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 27 条
[1]  
*AAOM, 2007, AAOM ORG STAT
[2]  
*AM COLL OST SCLER, 2007, WHAT IS SCLER ACOSPM
[3]  
Banks AR, 1991, J Orthop Med., V13, P54
[4]   Prolotherapy injections for chronic low-back pain [J].
Dagenais, S. ;
Yelland, M. J. ;
Del Mar, C. ;
Schoene, M. L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02)
[5]   Side effects and adverse events related to intraligamentous injection of sclerosing solutions (Prolotherapy) for back and neck pain: A survey of practitioners [J].
Dagenais, Simon ;
Ogunseitan, Adele ;
Haldeman, Scott ;
Wooley, James R. ;
Newcomb, Robert L. .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2006, 87 (07) :909-913
[6]  
Dagenais Simon, 2005, Spine J, V5, P310, DOI 10.1016/j.spinee.2004.09.011
[7]   Acute toxicity pilot evaluation of proliferol in rats and swine [J].
Dagenais, Simon ;
Ogunseitan, Oladele ;
Haldeman, Scott ;
Wooley, James R. ;
Zaldivar, Frank ;
Kim, Ronald C. .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2006, 25 (03) :171-181
[8]   A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain [J].
Dechow, E ;
Davies, RK ;
Carr, AJ ;
Thompson, PW .
RHEUMATOLOGY, 1999, 38 (12) :1255-1259
[9]   CAM therapies among primary care patients using opioid therapy for chronic pain [J].
Fleming S. ;
Rabago D.P. ;
Mundt M.P. ;
Fleming M.F. .
BMC Complementary and Alternative Medicine, 7 (1)
[10]  
Gedney E., 1937, OSTEOPATHIC PROFESSI, V4, P30, DOI DOI 10.1097/01.JSM.0000173268.05318.A4